Company intelligence / Profile preview

Eurofins Genomics Blue Heron

Bothell, Washington, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Eurofins Genomics Blue Heron (formerly Blue Heron Biotech/Blue Heron Biotechnology) is a commercial gene synthesis and molecular biology services provider offering complex DNA synthesis, custom cloning, plasmid preparation, and IVT mRNA production for research, drug discovery, vaccine development, and gene/cell therapy applications; it does not run its own therapeutic clinical programs.[8][9][10]

Modalities: DNA synthesisRNA therapymRNA-based drugsPlasmid DNA
Industry: Drug Discovery Services

Partnerships

OriGene Technologies (use of OriGene expression vector collection with Blue Heron gene synthesis)[9]Top 20 pharma and biotech companies as major customers for synthetic DNA and gene synthesis services[9][14]

Beyond the preview

Go deeper on Eurofins Genomics Blue Heron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurofins Genomics Blue Heron.

Explore the full profile